Nanomicelle formulation modifies the pharmacokinetic profiles and cardiac toxicity of daunorubicin

BACKGROUND: Treatment with daunorubicin (DNR) in acute myeloid leukemia is moderately effective and associated with significant side effects, including cardiac toxicity. We recently developed a nanomicellar formulation of DNR that specifically targets acute myeloid leukemia stem cells. MATERIALS &am...

Full description

Saved in:

Bibliographic Details
Main Authors:	Zhang, Hongyong, Li, Yuanpei, Lin, Tzu-yin, Xiao, Kai, Haddad, Ashraf S, Henderson, Paul T, Jonas, Brian A, Chen, Mingyi, Xiao, Wenwu, Liu, Ruiwu, Lam, Kit S, Pan, Chong-xian
Format:	Artigo
Language:	Inglês
Published:	2014
Subjects:	Article
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC4167557/ https://ncbi.nlm.nih.gov/pubmed/24628688 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/nnm.14.44
Tags:	Add Tag No Tags, Be the first to tag this record!

Nanomicelle formulation modifies the pharmacokinetic profiles and cardiac toxicity of daunorubicin

Similar Items